Aardvark Therapeutics Surges 11.66%, Tests $16 Resistance

$Aardvark Therapeutics(AARD)$

Aardvark Therapeutics (AARD) Surged +11.66%: Biotech Momentum Builds, $16 Resistance Tested

Latest Close Data

AARD closed at $15.61 on December 12th, up +$1.63 (+11.66%) from previous close of $13.98.

Stock trading 20.3% below 52-week high of $19.58, showing strong recovery from 52-week low of $4.88.

Core Market Drivers

Strong institutional buying drove momentum with net capital inflow of $572,400.

Large order purchases ($393,300) significantly outpaced selling ($54,200), indicating institutional confidence.

Biotech sector rotation and potential pipeline developments fueling investor interest.

Technical Analysis

Volume surged to 333,200 shares (1.31x ratio).
MACD shows bullish divergence with DIF at 0.863 above DEA at 0.220, generating strong buy signal.
RSI(6) hit extreme overbought at 89.1, while RSI(12) at 76.8 suggests continued momentum but approaching caution zone.

Key Price Levels

Primary Support: $14.00 (previous resistance now support)
Strong Resistance: $16.00 (today's high, critical breakout level)
Immediate Pivot: $15.20 (pullback support zone)

Valuation Perspective

Trading at P/B ratio of 2.77x with negative P/E of -24.1x due to current losses (EPS TTM: -$0.65). Market cap of $339M reflects speculative biotech premium typical for development-stage therapeutics.

Analyst Targets

Limited analyst coverage for this emerging biotech. Institutional ownership concentrated among Decheng Capital (18.05%) and venture partners, suggesting early-stage investment thesis remains intact.

Weekly Outlook

Expect consolidation between $14.50-$16.50 range. Breakout above $16.00 targets $18.00-$19.00 zone.

Volume sustainability above 300K shares crucial for continued uptrend. Watch for profit-taking near $16 resistance.

Risk Disclaimer

Biotech investments carry high volatility and clinical trial risks. This analysis is for informational purposes only and not investment advice.

For SG users only, Welcome to open a CBA today and enjoy access to a trading limit of up to SGD 20,000 with unlimited trading on SG, HK, and US stocks, as well as ETFs.

🎉Cash Boost Account Now Supports 35,000+ Stocks & ETFs – Greater Flexibility Now

Find out more here.

Complete your first Cash Boost Account trade with a trade amount of ≥ SGD1000* to get SGD 688 stock vouchers*! The trade can be executed using any payment type available under the Cash Boost Account: Cash, CPF, SRS, or CDP.
Click to access the activity

Other helpful links:

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.